Bashdar Mahmud Hussen ¹ Hamed Shoorei ² Mahdi Mohaqiq ³ Marcel E Dinger ⁴ Hazha Jamal Hidayat ⁵ Mohammad Taheri ^6* Soudeh Ghafouri-Fard ⁷

• ¹ Department of Pharmacognosy, College of Pharmacy, Hawler Medical University, Erbil, Kurdistan, Iraq
• ² Department of Anatomical Sciences, Faculty of Medicine, Birjand University of Medical Sciences, Birjand, Iran, Birjand, Iran
• ³ Wake Forest Institute for Regenerative Medicine, School of Medicine, Wake Forest University, Winston-Salem, North Carolina, United States
• ⁴ School of Biotechnology and Biomolecular Sciences, Faculty of Science, University of New South Wales, Sydney, New South Wales, Australia
• ⁵ Department of Biology, College of Education, Salahaddin University-Erbil, Erbil, Iraq, Erbil, Iraq
• ⁶ Urology and Nephrology Research Center, Shahid Beheshti University of Medical Sciences, Teheran, Tehran, Iran
• ⁷ Department of Genetics, Shahid Beheshti University of Medical Sciences, Tehran, Alborz, Iran

Incorrect Supplementary Material In the published article, the References column was incorrect in Supplementary Table 1. The corrected Supplementary Table is included at the end of this corrigendum. Supplementary Table 2 was missing from the original publication. This Supplementary Table is included at the end of this corrigendum. The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. Text correction A correction has been made to section miRNAs in EMT, Paragraph 1. This sentence previously stated: “In this type of cancer, miR-145-5p, miR-383-5p, miR-3622a-3p, miR-205 and miR-200b inhibit EMT process through targeting CDCA3, SGK1, SALL4, MDM4 and HIF-1α, respectively (Shang et al., 2017; Chong et al., 2019; Chang et al., 2020; Chen et al., 2020; Fan and Wang, 2020).” The corrected sentence appears below: “In colorectal cancer, miR-145-5p, miR-3622a-3p, miR-205 and miR-200b inhibit EMT through targeting CDCA3, SALL4, MDM4 and HIF-1α, respectively (Shang et al., 2017; Chang et al., 2020; Chen et al., 2020a; Fan and Wang 2020).” A correction has been made to section lncRNAs in EMT, Paragraph 1. The section previously included the following sentences: “CCAT1 is an oncogenic lncRNA in cervical cancer cells whose silencing has blocked proliferation, migratory potential, invasiveness and EMT process in these cells. CCAT1 silencing has led to down-regulation of Runx2 and suppression of PI3K/AKT signaling in cervical cancer cells PI3K/AKT signal (Li et al., 2020a). HAL is a down-regulated lncRNA in serous ovarian cancer tissues and cells. Up-regulation of HAL has suppressed invasive potential of these cells and enhanced their apoptosis. HAL has been shown to directly suppress expression of TWIST1. Functional studies has highlighted the role of HAL in regulation of EMT (Wu K. et al., 2020). In ovarian cancer, LINC00963, TC0101441, CCAT1 and PTAR promote EMT through modulation of miR-378g, KiSS1, miR-490-3p and miR-101-3p, respectively (Liang et al., 2018; Mu et al., 2018; Liu et al., 2020; Qiu et al., 2020).” The section was corrected with the sentence that appears below: “In ovarian cancer, TC0101441, CCAT1 and PTAR promote EMT through modulation of KiSS1, miR-490-3p and miR-101-3p, respectively (Liang et al., 2018; Mu et al., 2018; Qiu et al., 2020).” A correction has been made to section lncRNAs in EMT, Paragraph 2. The section previously included the following sentence: “Over-expression of LINC00963, FLVCR1-AS1 and LINC00261 has been associated with poor overall survival rate of patients with neoplasm (Yan et al., 2019; Gao et al., 2020; Liu et al., 2020).” The corrected sentence appears below: “Over-expression of FLVCR1-AS1 and LINC00261 has been associated with poor overall survival rate of patients with neoplasm (Yan et al., 2019; Gao et al., 2020).” Table 1 cites two retracted articles that should be removed from it: “30 pairs of CRC and ACTs Decreased miR-195-5p expression was linked with poor prognosis. Lin et al., 2019” “50 pairs of lung cancer and normal lung specimens High expression of miR-548e-5p was linked with longer overall survival. Jin et al., 2019” Table 2 cites two retracted articles that should be removed from it: “35 pairs of OS and ACTs - - - High expression of LINC00963 was linked with poor overall survival rate. High expression of LINC00963 was associated with metastasis rate of lymph nodes and FIGO stage. Liu et al., 2020” “76 pairs of CRC and ACTs - - - High expression of TUG1 was linked with poor OS. - Sun et al., 2018” The authors apologize for these errors and state that this does not change the scientific conclusions of the article in any way.